Drug Trial Radar · NCT03266588
Open Label Safety Study in Acute Treatment of Migraine
Last checked: Nov 20, 2026Latest source record: Feb 16, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,019
Actual
Start
Aug 30, 2017
Primary completion
Jul 15, 2019
Study completion Jul 15, 2019
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 30, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate safety and tolerability of BHV-3000 (rimegepant).
Conditions
- Migraine, With or Without Aura
Interventions
RimegepantDrug
75 mg oral tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With SAEs and AEs Leading to Discontinuation During the Treatment PeriodTime frame: PRN (2-8) and PRN (9-14) groups: Up to 52 weeks; Scheduled EOD + PRN group: Up to 12 weeks
- Number of Participants With Clinically Significant Laboratory Abnormalities During the Treatment PeriodTime frame: PRN (2-8) and PRN (9-14) groups: Up to 52 weeks: Scheduled EOD + PRN group: Up to 12 weeks
Locations
98 sites in 1 country. Site status is shown where the registry gives one.
Central Research Associates, Inc
Birmingham, Alabama
Coastal Clinical Research, Inc.
Mobile, Alabama
Thunderbird Internal Medicine / Radiant Research, Inc
Glendale, Arizona
Neurological Physicians of Arizona
Tempe, Arizona
Clinical Research Consortium Arizona
Tempe, Arizona
Woodland International Research Group, LLC
Little Rock, Arkansas
Woodland Research Northwest, LLC
Rogers, Arkansas
Pharmacology Research Institute
Encino, California
eStudySite
La Mesa, California
Collaborative Neuroscience Network, LLC
Long Beach, California
Pharmacology Research Institute
Los Alamitos, California
Pharmacology Research Institute
Newport Beach, California
Pacific Research Partners LLC
Oakland, California
National Research Institute
Panorama City, California
Optimus Medical Group
San Francisco, California
California Medical Clinic for Headache
Santa Monica, California
California Neuroscience Research Medical Group, Inc.
Sherman Oaks, California
Diablo Clinical Research, Inc
Walnut Creek, California
Clinical Trials of the Rockies
Denver, Colorado
AGA Clinical Trials
Hialeah, Florida
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida
Multi-Specialty Research Associates, Inc
Lake City, Florida
Renstar Medical Research
Ocala, Florida
Clinical Neuroscience Solutions, Inc
Orlando, Florida
Compass Research, LLC
Orlando, Florida
Ormond Medical Arts Pharmaceutical Research
Ormond Beach, Florida
Meridien Research
Tampa, Florida
Radiant Research, Inc.
Atlanta, Georgia
Meridian Clinical Research
Savannah, Georgia
Savannah Neurology Specialists
Savannah, Georgia
Christie Clinic, LLC
Champaign, Illinois
PMG Research of McFrland Clinic
Ames, Iowa
Heartland Research Associates, LLC
Augusta, Kansas
Heartland Research Associates, LLC
Newton, Kansas
Heartland Research Associates, LLC
Wichita, Kansas
Heartland Research Associates, LLC
Wichita, Kansas
Benchmark Research
Metairie, Louisiana
MedPharmics, LLC
Metairie, Louisiana
New Orleans Center for Clinical Research
New Orleans, Louisiana
Boston Clinical Trials, Inc.
Boston, Massachusetts
Showing 40 of 98 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.